NEUCA S.A. (WSE:NEU)
Poland · Delayed Price · Currency is PLN 668.00
-44.00 (-6.18%)
At close: Mar 26, 2026
NEUCA Revenue
In the year 2025, NEUCA had annual revenue of 13.64B PLN with 8.18% growth. NEUCA had revenue of 3.52B in the quarter ending December 31, 2025, with 9.31% growth.
Revenue
13.64B
Revenue Growth
+8.18%
P/S Ratio
0.22
Revenue / Employee
3.07M
Employees
4,445
Market Cap
2.98B
Revenue Chart
Revenue History
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Dec 31, 2025 | 13.64B | 1.03B | 8.18% |
| Dec 31, 2024 | 12.61B | 799.12M | 6.76% |
| Dec 31, 2023 | 11.81B | 580.45M | 5.17% |
| Dec 31, 2022 | 11.23B | 1.37B | 13.87% |
| Dec 31, 2021 | 9.86B | 619.37M | 6.70% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2017 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2016 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| Diagnostyka | 2.30B |
| Centrum Medyczne ENEL-MED | 820.59M |
| Synektik Spólka Akcyjna | 706.45M |
| Mercator Medical | 585.57M |
| Voxel | 568.83M |
| Selvita | 373.90M |
| Celon Pharma | 225.60M |
| Ryvu Therapeutics | 87.70M |